• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » INC Research names Carol Aliyar senior vice president, study start-up

INC Research names Carol Aliyar senior vice president, study start-up

July 17, 2014
CenterWatch Staff

INC Research, a global phase I to IV CRO has announced the promotion of Carol Aliyar to senior vice president, study start-up. Aliyar will be responsible for leading the company¹s global site engagement and study start-up efforts, including study start-up operations, site identification, site start-up and activation, ethics and regulatory submissions/approval and patient recruitment. Aliyar will focus on fostering strong site relationships to optimize timelines and deliver rapid study start-up for global clinical trials, establishing the foundation for successful collaboration across the duration of a study.

“Developing long-lasting relationships with clinical research sites is critically important to our ability to deliver best-in-class clinical development solutions for our customers,” said Alistair Macdonald, chief operating officer, INC Research. “Study start-up is an essential phase in this process, because it serves as the initial interaction point with sites and customers and defines the relationship for the duration of the trial.”

Prior to joining INC in September 2012 to lead site start-up and regulatory for Europe, Aliyar held senior management positions at global CROs and at an international biopharmaceutical company. INC Research’s team will deliver a personalized and integrated approach that optimizes the start-up experience through strengthened collaboration and improved information exchange with our site partners.

“With 48% of studies failing to meet enrollment targets and more than 11% unable to recruit a single patient, the industry faces many challenges today in trial execution,” said Aliyar. “My team is committed to establishing partnership principles with sites to ensure they are motivated and well supported to deliver on enrollment targets, which are vital to a study’s success.”

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing